This list is an analysis based on recent market events. It's not an investment recommendation.
About
Cellid, Co., Ltd. develops immunotherapeutic vaccines for cancer and/or infectious diseases therapies. It is developing BVAC-C for cervical, head and neck, anal, and sex organ cancer with human papilloma virus infection; BVAC-B for stomach, breast, and ovarian cancer with HER-2/neu antigen; and BVAC-P for prostate cancer, renal cell cancer, and glioblastoma with prostate acid phosphatase (PAP) and prostate-specific membrane (PSMA) antigens. The company is also developing BVAC-M for cancers, such as melanoma with GP100/MAGE-A3 antigens; BVAC-Neo. Cellid, Co., Ltd. was founded in 2006 and is headquartered in Seoul, South Korea.
The current price of 299660.KQ is ₩3,620 KRW — it has increased by +5.39% in the past 24 hours. Watch Cellid. stock price performance more closely on the chart.
What is Cellid. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cellid. stocks are traded under the ticker 299660.KQ.
What is Cellid. market cap?▼
Today Cellid. has the market capitalization of 106.8B
What is Cellid. revenue for the last year?▼
Cellid. revenue for the last year amounts to 8.33B KRW.
What is Cellid. net income for the last year?▼
299660.KQ net income for the last year is -24.52B KRW.